The current NVIV market cap is 2.23M. The company's latest EPS is USD -3.3779 and P/E is -0.22.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -2.8M | -2.46M | -2.49M | -2.09M | -2.83M |
Net Income | -2.76M | -2.36M | -2.33M | -1.94M | -2.7M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -12.77M | -11.5M | -9.1M | -9.9M | -10.65M |
Net Income | -23.42M | -11.83M | -9.07M | -9.9M | -10.49M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 13.36M | 18.82M | 15.65M | 13.33M | 9.58M |
Total Liabilities | 3.26M | 3.08M | 2.18M | 1.76M | 666k |
Total Equity | 10.1M | 15.75M | 13.48M | 11.58M | 8.92M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 18.38M | 9.33M | 21.91M | 21.77M | 18.82M |
Total Liabilities | 2.27M | 3.74M | 2.72M | 3.66M | 3.08M |
Total Equity | 16.11M | 5.58M | 19.19M | 18.12M | 15.75M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -8.29M | -10.48M | -3.2M | -5.66M | -7.94M |
Investing | -143k | -160k | 2k | 24k | 67k |
Financing | N/A | 7.96M | N/A | N/A | N/A |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -12.31M | -10.31M | -9.53M | -8.85M | -10.48M |
Investing | -65k | -12k | -41k | -77k | -160k |
Financing | 15.88M | 268k | 22.46M | 8.51M | 7.96M |
Market Cap | 2.23M |
Price to Earnings Ratio | -0.22 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.14 |
Price to Book Ratio | 0.14 |
Dividend Yield | - |
Shares Outstanding | 3.11M |
Average Volume (1 week) | 60.78k |
Average Volume (1 Month) | 33.01k |
52 Week Change | -63.04% |
52 Week High | 2.80 |
52 Week Low | 0.6015 |
Spread (Intraday) | 0.02 (2.53%) |
Company Name | InVivo Therapeutics Holdings Corporation |
Address |
401 ryland street reno, nevada 89502 |
Website | https://www.invivotherapeutics.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.